Short Interest in 22nd Century Group Inc (XXII) Decreases By 2.9%
22nd Century Group Inc (NYSEAMERICAN:XXII) was the recipient of a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 9,677,128 shares, a decline of 2.9% from the October 13th total of 9,966,801 shares. Based on an average daily volume of 4,425,009 shares, the short-interest ratio is presently 2.2 days. Currently, 9.1% of the shares of the company are sold short.
XXII has been the subject of several recent analyst reports. Zacks Investment Research lowered shares of 22nd Century Group from a “buy” rating to a “hold” rating in a report on Friday, August 18th. Chardan Capital boosted their price target on shares of 22nd Century Group from $3.50 to $11.50 and gave the stock a “buy” rating in a report on Monday, October 16th.
In related news, VP Michael Robert Moynihan sold 50,000 shares of the business’s stock in a transaction on Friday, September 29th. The shares were sold at an average price of $2.67, for a total value of $133,500.00. Following the completion of the transaction, the vice president now directly owns 867,220 shares in the company, valued at approximately $2,315,477.40. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Several institutional investors have recently added to or reduced their stakes in XXII. Wells Fargo & Company MN grew its holdings in shares of 22nd Century Group by 1,422.2% during the third quarter. Wells Fargo & Company MN now owns 68,500 shares of the biotechnology company’s stock worth $190,000 after buying an additional 64,000 shares in the last quarter. Bristol Advisors LLC purchased a new stake in shares of 22nd Century Group during the third quarter worth $201,000. Advisor Group Inc. grew its holdings in shares of 22nd Century Group by 49.3% during the third quarter. Advisor Group Inc. now owns 73,775 shares of the biotechnology company’s stock worth $204,000 after buying an additional 24,375 shares in the last quarter. Virtu KCG Holdings LLC grew its holdings in shares of 22nd Century Group by 300.9% during the second quarter. Virtu KCG Holdings LLC now owns 126,106 shares of the biotechnology company’s stock worth $221,000 after buying an additional 94,650 shares in the last quarter. Finally, Northern Trust Corp grew its holdings in shares of 22nd Century Group by 22.3% during the second quarter. Northern Trust Corp now owns 133,797 shares of the biotechnology company’s stock worth $234,000 after buying an additional 24,401 shares in the last quarter.
Shares of 22nd Century Group (NYSEAMERICAN XXII) opened at $2.18 on Wednesday. 22nd Century Group has a 1-year low of $0.81 and a 1-year high of $3.50.
22nd Century Group (NYSEAMERICAN:XXII) last issued its quarterly earnings results on Thursday, November 9th. The biotechnology company reported ($0.03) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.01). The company had revenue of $4.53 million during the quarter, compared to analysts’ expectations of $5.09 million. 22nd Century Group had a negative return on equity of 57.55% and a negative net margin of 86.10%. 22nd Century Group’s revenue was up 46.1% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.03) EPS.
COPYRIGHT VIOLATION NOTICE: “Short Interest in 22nd Century Group Inc (XXII) Decreases By 2.9%” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/11/14/short-interest-in-22nd-century-group-inc-xxii-decreases-by-2-9.html.
22nd Century Group Company Profile
Receive News & Ratings for 22nd Century Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.